scholarly article | Q13442814 |
P50 | author | Johanna Kuusisto | Q28516669 |
P2093 | author name string | Pertti Jääskeläinen | |
Tiina Heliö | |||
Petri Sipola | |||
Kirsi Lauerma | |||
Mika Laine | |||
Mika Tarkiainen | |||
Mikko Jalanko | |||
Kati Kivelä | |||
P2860 | cites work | Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland | Q59409774 |
Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy | Q64283009 | ||
Hypertrophic cardiomyopathy | Q84753761 | ||
Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly | Q24292234 | ||
Structural characterization of the C3 domain of cardiac myosin binding protein C and its hypertrophic cardiomyopathy-related R502W mutant | Q27694614 | ||
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction | Q28237729 | ||
Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes | Q28248327 | ||
Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency | Q28250719 | ||
Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese | Q28279418 | ||
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). | Q33164685 | ||
Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review | Q33167509 | ||
Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy | Q35899352 | ||
Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology | Q38584470 | ||
Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy | Q39711263 | ||
Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population | Q43668587 | ||
Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. | Q45921977 | ||
Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene | Q46598455 | ||
Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations | Q47874876 | ||
Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy | Q48612809 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5960 | |
P577 | publication date | 2019-04-11 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation | |
P478 | volume | 9 |
Search more.